Skip to the main content

Medicina familiaris Croatica : Journal of the Croatian Association of Family medicine, Vol. 27 No. 1-2, 2019.

Other

Indications for NOAC discontinuation according to bleeding risks - case report

Nada Ivičević orcid id orcid.org/0000-0003-4759-7302 ; Dom zdravlja Splitsko-dalmatinske županije
Marion Tomičić orcid id orcid.org/0000-0003-2148-3227 ; School of Medicine, University of Split, Split, Croatia

Full text: croatian pdf 262 Kb

page 59-65

downloads: 459

cite

Abstract


Vitamin K antagonists (eg warfarin) and new oral anticoagulants (NOAC) are used to prevent stroke and other embolic accidents in patients with non-valvular atrial fibrillation and in the management and prevention of venous thromboembolism. The choice and dosage of NOACs depends on renal function. Threfore it is necessary to determine creatinine clearance before their introduction. Special caution must be paid to patients with comorbidity and to drug interactions. Treatment with NOACs is particular challenge in the cases such as a major bleeding or surgical intervention.

Keywords

anticoagulants; vitamin K – antagonists; warfarin; stroke; atrial fibrillation; preoperative care

Hrčak ID:

230751

URI

https://hrcak.srce.hr/230751

Publication date:

20.12.2019.

Article data in other languages: croatian

Visits: 1.336 *